CA2161256C - Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur - Google Patents
Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur Download PDFInfo
- Publication number
- CA2161256C CA2161256C CA002161256A CA2161256A CA2161256C CA 2161256 C CA2161256 C CA 2161256C CA 002161256 A CA002161256 A CA 002161256A CA 2161256 A CA2161256 A CA 2161256A CA 2161256 C CA2161256 C CA 2161256C
- Authority
- CA
- Canada
- Prior art keywords
- pantoprazole
- pharmaceutically acceptable
- amount
- treatment
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5431893A | 1993-04-27 | 1993-04-27 | |
US08/054,318 | 1993-04-27 | ||
PCT/US1994/004543 WO1994024867A1 (fr) | 1993-04-27 | 1994-04-25 | Procedes et compositions permettant de traiter des troubles gastriques au moyen de pantoprazole (-) optiquement pur |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2161256A1 CA2161256A1 (fr) | 1994-11-10 |
CA2161256C true CA2161256C (fr) | 2004-06-29 |
Family
ID=21990236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002161256A Expired - Fee Related CA2161256C (fr) | 1993-04-27 | 1994-04-25 | Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur |
Country Status (6)
Country | Link |
---|---|
US (4) | US5888535A (fr) |
EP (1) | EP0695123A4 (fr) |
JP (1) | JPH08509736A (fr) |
AU (2) | AU6713194A (fr) |
CA (1) | CA2161256C (fr) |
WO (1) | WO1994024867A1 (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2161256C (fr) * | 1993-04-27 | 2004-06-29 | Nancy M. Gray | Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
SE9602442D0 (sv) * | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
WO1999056748A1 (fr) * | 1998-05-05 | 1999-11-11 | Sepracor Inc. | Compositions de demethylpantoprazole et procedes les concernant |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US8287554B2 (en) | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
WO2002026210A2 (fr) * | 2000-09-29 | 2002-04-04 | Geneva Pharmaceuticals Inc. | Formulation d'inhibiteur de la pompe à protons |
MY137726A (en) * | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
EP1575941B1 (fr) | 2002-12-06 | 2012-04-11 | Nycomed GmbH | Procédé de préparation de (S)-pantoprazole |
PT1578742E (pt) | 2002-12-06 | 2013-01-24 | Nycomed Gmbh | Processo para preparar compostos activos opticamente puros |
US20060235053A1 (en) * | 2003-05-06 | 2006-10-19 | Atlanta Pharma Ag | Agents for the treatment of lower abdominal disorders |
PE20050150A1 (es) * | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
CL2004000983A1 (es) * | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
WO2005011691A1 (fr) * | 2003-07-31 | 2005-02-10 | Altana Pharma Ag | Liaison amelioree du pantoprazole et de la pompe a protons |
US20070027189A1 (en) * | 2003-09-18 | 2007-02-01 | Altana Pharma Ag | Use of known active ingredients as radical scavengers |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2005074930A1 (fr) * | 2004-01-28 | 2005-08-18 | Altana Pharma Ag | Combinaisons pharmaceutiques de (s) -pantoprazole avec nsaid ou des corticosteroides |
WO2005074898A2 (fr) * | 2004-01-28 | 2005-08-18 | Altana Pharma Ag | Nouvelle combinaison pour le traitement d'helicobacter pylori |
US20080234326A1 (en) * | 2004-01-28 | 2008-09-25 | Altana Pharma Ag | Novel Salts of Pantoprazole and (S) - Pantoprazole |
WO2005074932A1 (fr) * | 2004-01-28 | 2005-08-18 | Altana Pharma Ag | Utilisation de (s)-pantoprazole magnesium pour le traitement de troubles des voies respiratoires |
WO2005074931A1 (fr) * | 2004-01-28 | 2005-08-18 | Altana Pharma Ag | Produits composes pharmaceutiques comprenant (s)-pantoprazole |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
CN101250181B (zh) * | 2008-03-26 | 2011-04-27 | 江苏奥赛康药业有限公司 | S-泮托拉唑钠 |
GB2471619B (en) * | 2008-03-31 | 2012-10-31 | Council Scient Ind Res | Method for the simultaneous preparation of 3-acetoxy-17-acetamdo-16-formyl-androst-5,16-diene and 3-acetoxy-2'-chloro-5-androsteno[17,6-B]pyridine |
EP3225484B1 (fr) | 2016-03-31 | 2018-10-24 | Ford Global Technologies, LLC | Procédé de commande de la transition d'un véhicule automobile vers et hors d'un mode de fonctionnement en roue libre |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
CA2161256C (fr) * | 1993-04-27 | 2004-06-29 | Nancy M. Gray | Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur |
-
1994
- 1994-04-25 CA CA002161256A patent/CA2161256C/fr not_active Expired - Fee Related
- 1994-04-25 JP JP6524466A patent/JPH08509736A/ja active Pending
- 1994-04-25 EP EP94914907A patent/EP0695123A4/fr not_active Withdrawn
- 1994-04-25 WO PCT/US1994/004543 patent/WO1994024867A1/fr active Application Filing
- 1994-04-25 AU AU67131/94A patent/AU6713194A/en not_active Abandoned
-
1996
- 1996-12-23 US US08/772,944 patent/US5888535A/en not_active Expired - Lifetime
-
1998
- 1998-05-28 AU AU69044/98A patent/AU6904498A/en not_active Abandoned
-
2001
- 2001-02-14 US US09/783,683 patent/US20010008899A1/en not_active Abandoned
-
2002
- 2002-09-26 US US10/256,518 patent/US20030086968A1/en not_active Abandoned
-
2004
- 2004-01-14 US US10/757,059 patent/US6953808B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20040142032A1 (en) | 2004-07-22 |
WO1994024867A1 (fr) | 1994-11-10 |
AU6904498A (en) | 1998-07-16 |
US6953808B2 (en) | 2005-10-11 |
EP0695123A4 (fr) | 1996-09-11 |
US20010008899A1 (en) | 2001-07-19 |
US5888535A (en) | 1999-03-30 |
US20030086968A1 (en) | 2003-05-08 |
EP0695123A1 (fr) | 1996-02-07 |
CA2161256A1 (fr) | 1994-11-10 |
JPH08509736A (ja) | 1996-10-15 |
AU6713194A (en) | 1994-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2161256C (fr) | Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur | |
US20050222211A1 (en) | S(-)rabeprazole compositions and methods | |
US20030008903A1 (en) | R-lansoprazole compositions and methods | |
US20020019420A1 (en) | Methods and compositions for treating gastric disorders using optically pure (+)-pantoprazole | |
EP1056457A1 (fr) | Compositions de s-lansoprazole et procedes d'utilisation | |
US6174902B1 (en) | R-rabeprazole compositions and methods | |
AU2003204192B2 (en) | Methods and Compositions for Treating Gastric Disorders Using Optically Pure (-) Pantoprazole | |
AU3870599A (en) | R-rabeprazole compositions and methods | |
CA2337886C (fr) | Compositions pharmaceutiques contenant de l'hydroxylansoprazole et utilisations de ces dernieres | |
AU2003257509A1 (en) | S-rabeprazole compositions and methods | |
AU2003268822A1 (en) | R-raberprazole compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |